[Effect of fenicaberan and xavin on peripheral hemodynamic and blood coagulability indices in patients with chronic ischemic heart disease]. 1988

B Iu Shpak, and E M Neĭko, and M V Debenklo, and A S Lazho, and Z V Duma

UI MeSH Term Description Entries
D008297 Male Males
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001572 Benzofurans Compounds that contain a BENZENE ring fused to a furan ring. Coumarones,Diphenylbenzofuran

Related Publications

B Iu Shpak, and E M Neĭko, and M V Debenklo, and A S Lazho, and Z V Duma
August 1987, Vrachebnoe delo,
B Iu Shpak, and E M Neĭko, and M V Debenklo, and A S Lazho, and Z V Duma
December 1990, Vrachebnoe delo,
B Iu Shpak, and E M Neĭko, and M V Debenklo, and A S Lazho, and Z V Duma
August 1983, Vrachebnoe delo,
B Iu Shpak, and E M Neĭko, and M V Debenklo, and A S Lazho, and Z V Duma
October 1967, Terapevticheskii arkhiv,
B Iu Shpak, and E M Neĭko, and M V Debenklo, and A S Lazho, and Z V Duma
April 1986, Vrachebnoe delo,
B Iu Shpak, and E M Neĭko, and M V Debenklo, and A S Lazho, and Z V Duma
January 1989, Vrachebnoe delo,
B Iu Shpak, and E M Neĭko, and M V Debenklo, and A S Lazho, and Z V Duma
September 1991, Kardiologiia,
B Iu Shpak, and E M Neĭko, and M V Debenklo, and A S Lazho, and Z V Duma
August 1988, Vrachebnoe delo,
B Iu Shpak, and E M Neĭko, and M V Debenklo, and A S Lazho, and Z V Duma
August 1977, Vrachebnoe delo,
B Iu Shpak, and E M Neĭko, and M V Debenklo, and A S Lazho, and Z V Duma
February 1999, Clinical cardiology,
Copied contents to your clipboard!